Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin.
The lipopeptidic antibiotic daptomycin is reported to reduce experimental tobramycin nephrotoxicity (D. Beauchamp, M. Pellerin, P. Gourde, M. Pettigrew and M. G. Bergeron, Antimicrob. Agents Chemother. 34:139-147, 1990; C. A. Wood, H. C. Finkbeiner, S. J. Kohlhepp, P. W. Kohnen, and D. C. Gilbert, A...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1994
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284536/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.742 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
